Home >> About >> People >> Robin D. Campbell

Robin D. Campbell

Lecturer, Technology Management Program
Aptitude Medical Systems, Acelot Inc., Naryx Pharma, Amgen Inc.

Robin’s professional career spans more than 25 years and includes both U.S. and international experience in pharmaceutical and biotechnology sales, marketing, product development and general management.  He currently is an active angel investor and is Chairman of the Board of Aptitude Medical Systems, an early stage company creating high-performance aptamers for research, diagnostic and therapeutic use.  He is also on the Board of Directors of Acelot, Inc. a company using bioinformatics technology to discover new drug candidates for neurologic diseases.

From 2004 to 2008, Robin was President and CEO of Naryx Pharma, a venture-backed specialty pharmaceutical company developing novel, topically delivered treatments for chronic sinusitis and other conditions treatable by intranasal drug delivery.  Prior to joining Naryx Pharma, Robin was at Amgen Inc., where his last position was Vice President and General Manager of the Oncology Business Unit.  In this role, Robin led an integrated team responsible for the marketing, sales and medical development of products generating over $1 billion in revenue.

In the TMP, Robin teaches courses on Business Strategy and Leadership, New Product Development and Marketing.    



Tech Venture Experience: 

Amgen Inc., Naryx Pharma, Aptitude Medical Systems